Germline mutations in PALB2, ATM, and CHEK2 [69] are also associated with breast cancer risks as high as those associated with BRCA1/2 mutations and are often referred to as BRCA-like breast cancer [67]. Here, CHEK2 is linked to breast carcinoma.